ArticleCancer medicine2025

Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Ya-Lan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.